Fulcrum therapeutics announces multiple presentations at the 28th annual fshd society international research congress (irc)

– fulcrum to host conference call on june 24, 2021 at 8:00am et to present results from phase 2b redux4 trial with losmapimod in facioscapulohumeral muscular dystrophy (fshd) – – fulcrum to host conference call on june 24, 2021 at 8:00am et to present results from phase 2b redux4 trial with losmapimod in facioscapulohumeral muscular dystrophy (fshd) –
FULC Ratings Summary
FULC Quant Ranking